The Sjögren’s Syndrome-Associated Autoantigen Ro52 Is an E3 Ligase That Regulates Proliferation and Cell Death-Reference-Cited by-同舟云学术

The Sjögren’s Syndrome-Associated Autoantigen Ro52 Is an E3 Ligase That Regulates Proliferation and Cell Death

Published:2006-05-02 Issue:10 Volume:176 Page:6277-6285
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Espinosa Alexander,Zhou Wei,Ek Monica,Hedlund Malin,Brauner Susanna,Popovic Karin,Horvath Linn,Wallerskog Therese,Oukka Mohamed,Nyberg Filippa,Kuchroo Vijay K.,Wahren-Herlenius Marie

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference46 articles.

1. Jonsson, R., H. J. Haga, T. Gordon. 2001. Sjögrens’s Syndrome Lippincott Williams & Wilkins, Philadelphia.

2. Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sj�gren's syndrome

3. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand.

4. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenic mechanisms of disease in idiopathic inflammatory myopathies: autoantibodies as clues;Frontiers in Immunology;2024-08-30

2. Clinical features of patients with systemic sclerosis positive for anti-SS-A antibody: a cohort study of 156 patients;Arthritis Research & Therapy;2024-05-03

3. SKP2 promotes the metastasis of pancreatic ductal adenocarcinoma by suppressing TRIM21-mediated PSPC1 degradation;Cancer Letters;2024-04

4. Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions;Blood Advances;2024-02-13

5. The interconnected roles of TRIM21/Ro52 in systemic lupus erythematosus, primary Sjögren’s syndrome, cancers, and cancer metabolism;Cancer Cell International;2023-11-22